| Literature DB >> 31073032 |
Sylvia C Hewitt1, Sydney L Lierz2, Marleny Garcia2, Katherine J Hamilton2, Artiom Gruzdev3, Sara A Grimm4, John P Lydon5, Francesco J Demayo6, Kenneth S Korach2.
Abstract
Insulin-like growth factor 1 (IGF1) is primarily synthesized in and secreted from the liver; however, estrogen (E2), through E2 receptor α (ERα), increases uterine Igf1 mRNA levels. Previous ChIP-seq analyses of the murine uterus have revealed a potential enhancer region distal from the Igf1 transcription start site (TSS) with multiple E2-dependent ERα-binding regions. Here, we show E2-dependent super enhancer-associated characteristics and suggest contact between the distal enhancer and the Igf1 TSS. We hypothesized that this distal super-enhancer region controls E2-responsive induction of uterine Igf1 transcripts. We deleted 430 bp, encompassing one of the ERα-binding sites, thereby disrupting interactions of the enhancer with gene-regulatory factors. As a result, E2-mediated induction of mouse uterine Igf1 mRNA is completely eliminated, whereas hepatic Igf1 expression remains unaffected. This highlights the central role of a distal enhancer in the assembly of the factors necessary for E2-dependent interaction with the Igf1 TSS and induction of uterus-specific Igf1 transcription. Of note, loss of the enhancer did not affect fertility or uterine growth responses. Deletion of uterine Igf1 in a PgrCre;Igf1f/f model decreased female fertility but did not impact the E2-induced uterine growth response. Moreover, E2-dependent activation of uterine IGF1 signaling was not impaired by disrupting the distal enhancer or by deleting the coding transcript. This indicated a role for systemic IGF1, suggested that other growth mediators drive uterine response to E2, and suggested that uterine-derived IGF1 is essential for reproductive success. Our findings elucidate the role of a super enhancer in Igf1 regulation and uterine growth.Entities:
Keywords: chromatin immunoprecipitation (ChiP); chromatin structure; estrogen receptor; hormone receptor; insulin-like growth factor (IGF); mouse; nuclear receptor; reproduction; transcription enhancer; uterus
Mesh:
Substances:
Year: 2019 PMID: 31073032 PMCID: PMC6597841 DOI: 10.1074/jbc.RA119.008759
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157